Related Experiment Video

Updated: Jul 15, 2026

Cell Population Analyses During Skin Carcinogenesis
06:53

Cell Population Analyses During Skin Carcinogenesis

Published on: August 21, 2013

GSDMA deficiency impairs cutaneous squamous cell carcinoma growth

Manyun Li1, Jinghan Song1, Qin Gao1

  • 1Ministry of Education (MOE) Key Laboratory of Model Animals for Disease Study, State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Key Laboratory of Molecular Medicine, Model Animal Research Center, National Resource Center for Mutant Mice of China, Nanjing Drum Tower Hospital, School of Medicine, Nanjing University, Nanjing, China.

Frontiers in Oncology
|July 14, 2026
PubMed

Insights

Gasdermin A (GSDMA) promotes skin cancer (cSCC) by enhancing cell proliferation. Its deficiency inhibits cSCC progression, suggesting GSDMA as a potential therapeutic target for this skin malignancy.

Area of Science:

  • Oncology
  • Dermatology
  • Molecular Biology

Background:

  • Gasdermin A (GSDMA) is expressed in epithelial cells, with known roles in pyroptosis.
  • The physiological function of GSDMA, particularly in skin, remains largely undetermined.
  • Cutaneous squamous cell carcinoma (cSCC) is a common skin cancer with significant morbidity.

Purpose of the Study:

  • To investigate the role of GSDMA in the initiation and progression of cutaneous squamous cell carcinoma (cSCC).
  • To elucidate the molecular mechanisms by which GSDMA influences cSCC development.

Main Methods:

  • Utilized mouse models with Gsdma1/2/3 deficiency to assess cSCC initiation and progression.
  • Analyzed GSDMA expression levels in human cSCC tissues.
  • Investigated the involvement of the EGFR-AKT signaling pathway in GSDMA-mediated cSCC proliferation.

Main Results:

  • Gsdma1/2/3 deficiency significantly inhibited cSCC initiation and progression in mice.
  • Gsdma1 expression was significantly upregulated in human cSCC samples, while Gsdma2 and Gsdma3 were not.
  • GSDMA deficiency impaired EGFR-AKT axis-mediated cell proliferation during cSCC progression.

Conclusions:

  • GSDMA plays a critical promoting role in the proliferation and progression of cutaneous squamous cell carcinoma.
  • GSDMA may serve as a potential therapeutic target for treating cSCC.
  • Understanding GSDMA's function provides new insights into skin cancer development.
Keywords:
CSCCEGFRGSDMASCCcell proliferation

More Related Videos

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)04:12

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)

Published on: December 19, 2019

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...